Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials

被引：0
|
作者：
Meyers, Paul A. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10065 USA
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 70卷 / 11期
关键词：
D O I：
10.1002/pbc.30617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: Pooled analysis of open-label clinical trials
    Uthman, Basim M.
    Bazil, Carl W.
    Beydoun, Ahmad
    Schulze-Bonhage, Andreas
    Benabou, Reina
    Whalen, Ed
    Emir, Birol
    Griesing, Teresa
    Leon, Teresa
    EPILEPSIA, 2010, 51 (06) : 968 - 978
  • [22] Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients (Vol 13, 1280587, 2023)
    Mosleh, Ema
    Snyder, Stacy
    Wu, Ningying
    Willis, Daniel N.
    Malone, Rema
    Hayashi, Robert J.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study
    Rubin-Kahana, Dafna Sara
    Shelef, Assaf
    Weizman, Abraham
    Gothelf, Doron
    Timinski, Igor
    Spivak, Baruch
    Stryjer, Rafael
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (04) : 179 - 183
  • [24] The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial
    Chen, Li-Wei
    Chang, Liang-Che
    Hua, Chung-Ching
    Liu, Ching-Jung
    Chou, Tien-Shin
    Lin, Chih-Lang
    Chien, Rong-Nan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [25] Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials
    Johnston, Christine
    Saracino, Misty
    Kuntz, Steve
    Magaret, Amalia
    Selke, Stacy
    Huang, Meei-Ii
    Schiffer, Joshua T.
    Koelle, David M.
    Corey, Lawrence
    Wald, Anna
    LANCET, 2012, 379 (9816): : 641 - 647
  • [26] Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial
    Guan, Jia-Lun
    Hu, Yun-Lian
    An, Ping
    He, Qiong
    Long, Hui
    Zhou, Lin
    Chen, Zhi-Fen
    Xiong, Jian-Guang
    Wu, Shi-Sheng
    Ding, Xiang-Wu
    Luo, He-Sheng
    Li, Pei-Yuan
    PHARMACOTHERAPY, 2022, 42 (03): : 224 - 232
  • [27] High-dose terazosin therapy (5 mg) in Korean patients with lower urinary tract symptoms with or without concomitant hypertension: A prospective, open-label study
    Kwak, Cheol
    Lee, Jeong Ki
    Ku, Ja Hyeon
    YONSEI MEDICAL JOURNAL, 2007, 48 (06) : 994 - 1000
  • [28] Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study
    Tanaka, H.
    Oki, E.
    Tsugawa, K.
    Nonaka, K.
    Suzuki, K.
    Ito, E.
    LUPUS, 2007, 16 (11) : 896 - 900
  • [29] Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-Dose Cisplatin and Radiation Therapy
    Porosnicu, M.
    Faig, J.
    Taylor, R. C.
    Porosnicu, K. A. Rodriguez
    Murea, M.
    Bonomi, M.
    Greven, K. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 908 - 908
  • [30] A phase 1, open-label, dose-escalation study of olaratumab as a single agent and in combination with doxorubicin, vincristine/irinotecan, or high-dose ifosfamide in pediatric patients with relapsed or refractory solid tumors.
    Mascarenhas, Leo
    Tai, Datchen Fritz
    Bishop, William
    DuBois, Steven G.
    Theodore
    Laetsch, Willis
    Levy, Donna Elise
    Pillay, Sada
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345